快而精医药 | 46.85 -0.08 -0.17% | ||
| QGEN | |||
| 高 47.59 | 开 47.37 | 量 131.15万股 | 总市值 101.59亿 |
| 低 46.45 | 换 0.60% | 额 6157.38万 | 市盈TTM 27.21 |
分时
5日
日K
周K
月K
季K
年K
快而精医药(QGEN)
09-02 18:05
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000062 Act: 34 Size: 223 KB 网页链接
快而精医药(QGEN)
08-22 05:25
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000057 Act: 34 Size: 1 MB 网页链接
快而精医药(QGEN)
08-16 04:55
$快而精医药(QGEN)$ 144 Report of proposed sale of securities Accession Number: 0001015820-25-000054 Act: 33 Size: 6 KB 网页链接
快而精医药(QGEN)
08-16 04:35
$快而精医药(QGEN)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-005910 Act: 33 Size: 8 KB 网页链接
快而精医药(QGEN)
08-15 06:15
$快而精医药(QGEN)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-005859 Act: 33 Size: 7 KB 网页链接
快而精医药(QGEN)
08-14 06:15
$快而精医药(QGEN)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-005796 Act: 33 Size: 5 KB 网页链接
快而精医药(QGEN)
08-12 22:45
$快而精医药(QGEN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902219-25-000274 Act: 34 Size: 17 KB 网页链接
快而精医药(QGEN)
08-07 18:15
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000049 Act: 34 Size: 497 KB 网页链接
快而精医药(QGEN)
06-30 18:05
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000044 Act: 34 Size: 145 KB 网页链接
快而精医药(QGEN)
06-02 18:05
$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-25-000040 Act: 34 Size: 43 KB 网页链接
快而精医药(QGEN)
05-15 03:05
$快而精医药(QGEN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000912938-25-000062 Act: 34 Size: 6 KB 网页链接
快而精医药(QGEN)
05-13 18:05
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000037 Act: 34 Size: 985 KB 网页链接
快而精医药(QGEN)
05-09 18:05
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000034 Act: 34 Size: 392 KB 网页链接
快而精医药(QGEN)
04-09 18:05
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000030 Act: 34 Size: 145 KB 网页链接
快而精医药(QGEN)
03-31 18:05
$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-25-000027 Act: 34 Size: 49 MB 网页链接
快而精医药(QGEN)
03-31 18:05
$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-25-000028 Act: 34 Size: 101 KB 网页链接
快而精医药(QGEN)
02-07 19:05
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000015 Act: 34 Size: 495 KB 网页链接
快而精医药(QGEN)
02-06 22:45
$快而精医药(QGEN)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902219-25-000015 Act: 34 Size: 16 KB 网页链接
快而精医药(QGEN)
01-17 06:05
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000012 Act: 34 Size: 153 KB 网页链接
快而精医药(QGEN)
01-14 04:55
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000008 Act: 34 Size: 147 KB 网页链接